SCHEMBL17899574

SCHEMBL17899574

COc1cccc(OC)c1/C=C1\CCC/C(=C\c2c(OC)cccc2OC)C1=O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
NOD2 Q9HC29 2/20 0.57
CRHBP P24387 1/20 0.56
CRHR2 Q13324 1/20 0.56
HSD17B3 P37058 1/20 0.55
NFE2L2 Q16236 2/20 0.55
EGFR P00533 7/20 0.55
CYP1A2 P05177 2/20 0.54
JUN P05412 1/20 0.54
MME P08473 1/20 0.54
NFKB1 P19838 1/20 0.54
XDH P47989 2/20 0.49
LMNA P02545 2/20 0.49
MAPT P10636 2/20 0.49
KDM4E B2RXH2 1/20 0.49
POLB P06746 1/20 0.49
CYP3A4 P08684 1/20 0.49
HPGD P15428 1/20 0.49
XBP1 P17861 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25842300 0.92 MEN1 (0.50) MEN1KMT2ANOD2CRHBPCRHR2
SCHEMBL3438522 0.85 EGFR (0.51) MEN1KMT2ANOD2CRHBPCRHR2
SCHEMBL3438524 0.85 EGFR (0.51) MEN1KMT2ANOD2CRHBPCRHR2
SCHEMBL17899552 0.85 MAPT (0.56) MEN1KMT2ACRHBPCRHR2EGFR
SCHEMBL16745481 0.81 EGFR (0.77) MEN1KMT2ANOD2CRHBPCRHR2
SCHEMBL17899573 0.81 CRHBP (0.76) MEN1KMT2ANOD2CRHBPCRHR2
SCHEMBL17899518 0.80 NFE2L2 (0.58) NFE2L2EGFRLMNAMAPTKDM4E
SCHEMBL17899529 0.80 MEN1 (0.59) MEN1KMT2ANOD2EGFRLMNA
SCHEMBL25842347 0.79 ALDH1A1 (0.50) CRHBPCRHR2EGFRLMNAMAPT
SCHEMBL5690775 0.77 ACHE (0.58) MEN1KMT2ANFKB1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357200-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS BAYLOR COLLEGE OF MEDICINE (US) 2023-11-09 US disclosed
US-11708350-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents BAYLOR COLLEGE OF MEDICINE (US) 2023-07-25 US disclosed
US-11312676-B2 Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer BAYLOR COLLEGE OF MEDICINE (US) 2022-04-26 US disclosed
US-20210115017-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS BAYLOR COLLEGE OF MEDICINE (US) 2021-04-22 US disclosed
US-10875841-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents BAYLOR COLLEGE OF MEDICINE (US) 2020-12-29 US disclosed
US-20200071300-A1 Small Molecule Stimulators of Steroid Receptor Coactivator-3 and Methods of Their Use as Cardioprotective and/or Vascular Regenerative Agents BAYLOR COLLEGE OF MEDICINE (US) 2020-03-05 US disclosed
WO-2016109470-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR PROTEINS AND THEIR USE IN THE TREATMENT OF CANCER BAYLOR COLLEGE OF MEDICINE (US) 2016-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200071300-A1 Small Molecule Stimulators of Steroid Receptor Coactivator-3 and Methods of Their Use as Cardioprotective and/or Vascular Regenerative Agents NCOA3, FABP3, NCOA1 MEN1 4718/4885KMT2A 4286/4885NOD2 2883/4885
US-11312676-B2 Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer NCOA2, NCOA1, NCOA3 MEN1 3952/4885KMT2A 3709/4885NOD2 3604/4885
US-20210115017-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS NCOA3, FABP3, NCOA1 MEN1 4718/4885KMT2A 4286/4885NOD2 2883/4885
US-11708350-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents NCOA3, FABP3, NCOA1 MEN1 4718/4885KMT2A 4286/4885NOD2 2883/4885
US-10875841-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents NCOA3, FABP3, NCOA1 MEN1 4718/4885KMT2A 4286/4885NOD2 2883/4885
US-20230357200-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS NCOA3, FABP3, NCOA1 MEN1 4718/4885KMT2A 4286/4885NOD2 2883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.